Hybrid human leukocyte interferons
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 7, 1987
Issued Date -
N/A
app pub date -
Jun 20, 1984
filing date -
Sep 25, 1981
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed herein are methods and means of microbially preparing novel human hybrid leukocyte interferons, useful in the treatment of viral and neoplastic diseases, by DNA recombination of parental interferon genes, taking advantage of common restriction endonuclease cleavage sites therein and in carrier expression plasmids.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully